Stocks
Novartis (NVS) EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 33 061 | 16 389 | 16 389 | 16 389 | 18 469 | 19 100 | ||
| Changes by years, y/y, % | 0% | -50% | 0% | 0% | +13% | -3.2% | |||
Novartis. EBITDA US GAAP, bln rub
Novartis. EBITDA US GAAP, changes, %
Novartis. EBITDA US GAAP, sum by quarters, bln rub
Novartis (NVS) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 4 818 | 4 885 | 4 182 | 4 943 | 5 090 | 19 100 | |
| Changes by years, y/y, % | +19% | +17% | +7% | 0% | +6% | |||
| Changes by quarters, q/q, % | -3% | +1% | -14% | +18% | +3% | |||
